Cited by 345Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

Large C9orf72 Hexanucleotide Repeat Expansions Are Seen in Multiple Neurodegenerative Syndromes and Are More Frequent Than Expected in the UK Population

Open access
Beck, Jon, Poulter, Mark, Hensman, Davina, Rohrer, Jonathan D., Mahoney, Colin J., Adamson, Gary, Campbell, Tracy, Uphill, James +19 more·2013·The American Journal of Human Genetics

Abstract

Hexanucleotide repeat expansions in C9orf72 are a major cause of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Understanding the disease mechanisms and a method for clinical diagnostic genotyping have been hindered because of the difficulty in estimating the expansion size. We found 96 repeat-primed PCR expansions: 85/2,974 in six neurodegenerative diseases cohorts (FTLD, ALS, Alzheimer disease, sporadic Creutzfeldt-Jakob disease, Huntington disease-like syndrome, and other nonspecific neurodegenerative disease syndromes) and 11/7,579 (0.15%) in UK 1958 birth cohort (58BC) controls. With the use of a modified Southern blot method, the estimated expansion range (smear maxima) in cases was 800-4,400. Similarly, large expansions were detected in the population controls. Differences in expansion size and morphology were detected between DNA samples from tissue and cell lines. Of those in whom repeat-primed PCR detected expansions, 68/69 were confirmed by blotting, which was specific for greater than 275 repeats. We found that morphology in the expansion smear varied among different individuals and among different brain regions in the same individual. Expansion size correlated with age at clinical onset but did not differ between diagnostic groups. Evidence of instability of repeat size in control families, as well as neighboring SNP and microsatellite analyses, support multiple expansion events on the same haplotype background. Our method of estimating the size of large expansions has potential clinical utility. C9orf72-related disease might mimic several neurodegenerative disorders and, with potentially 90,000 carriers in the United Kingdom, is more common than previously realized.

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2013.01.011

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • C9orf72 expansion mutations are associated with ALS/FTLD and also with symptoms reminiscent of Parkinson disease, Alzheimer disease, Huntington disease, and corticobasal syndrome.

    “For instance, C9orf72 expansion mutations are associated not only with ALS/FTLD, but also with symptoms reminiscent of Parkinson disease, Alzheimer disease, Huntington disease, and corticobasal syndrome, reinforcing the imperfect connection between clinical and molecular phenotypes and emphasizing the need for molecular diagnostics [155–164].”

Cites

Flagged first, then by citations

1 of the 25 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Beck, J., Poulter, M., Hensman, D., Rohrer, J. D., Mahoney, C. J., Adamson, G., Campbell, T., Uphill, J., Borg, A., Fratta, P., Orrell, R. W., Malaspina, A., Rowe, J., Brown, J., Hodges, J., Sidle, K., Polke, J. M., Houlden, H., Schott, J. M., Fox, N. C., Rossor, M. N., Tabrizi, S. J., Isaacs, A. M., Hardy, J., Warren, J. D., Collinge, J., & Mead, S.
Affiliations
  • MRC Prion Unit (GB)
  • UCL Queen Square Institute of Neurology (GB)
  • National Hospital for Neurology and Neurosurgery (GB)
  • Queen Mary University of London (GB)
  • University of Cambridge (GB)
Corresponding author
Mead, Simon
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2013-03
Volume
92
Issue
3
Pages
345-353
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2026340703
Cited by
345
References
25
Citations by year
2026: 4 · 2025: 6 · 2024: 24 · 2023: 24 · 2022: 31 · 2021: 21 · 2020: 20 · 2019: 21 · 2018: 27 · 2017: 21 · 2016: 24 · 2015: 44 · 2014: 41 · 2013: 35
FWCI
30.46
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Wellcome Trust (068545/Z/02), 088324, 091673/Z/10/Z, 068545)
  • National Institute for Health and Care Research (NF-SI-0512-10033, ACF-2009-18-016, NF-SI-0508-10123)
  • Motor Neurone Disease Association (Orrell/Apr11/6075)
  • Medical Research Council (MR/J004758/1, MR/J003832/1)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
C9orf72, hexanucleotide repeat expansion, repeat-primed PCR, Southern blot, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, Alzheimer's disease, Creutzfeldt-Jakob disease, repeat instability, haplotypes, age of onset, 1958 British birth cohort
MeSH terms
C9orf72 Protein, Amyotrophic Lateral Sclerosis, Brain, DNA, United Kingdom, Haplotypes, Humans, Nerve Degeneration, Proteins, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, DNA Repeat Expansion, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review